ArticleProceedings (Baylor University. Medical Center)2023
Recurrent malignant ovarian adenocarcinoma with central nervous system metastasis successfully treated with paclitaxel, carboplatin, capecitabine, and gemcitabine.
Soroush Shahrokh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.